Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

11.5K
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
11.5K
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

754
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
754
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

625
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
625
Coagulation01:09

Coagulation

5.1K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
5.1K
Antimicrobial Proteins01:23

Antimicrobial Proteins

939
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
939
Humoral Immune Responses01:36

Humoral Immune Responses

71.9K
Overview
71.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interpretable Machine Learning with SHAP Identifies Key Biomarkers in a Multi-Factorial Spectrum of Age-Related Neurological and Metabolic Conditions.

International journal of molecular sciences·2026
Same author

Immunological Profile and Markers of Endothelial Dysfunction in Elderly Patients with Cognitive Impairments.

International journal of molecular sciences·2024
Same author

The Role of the Complement System in the Pathogenesis of Infectious Forms of Hemolytic Uremic Syndrome.

Biomolecules·2024
Same author

Searching for New Biomarkers to Assess COVID-19 Patients: A Pilot Study.

Metabolites·2023
Same author

A Moderate Decrease in ADAMTS13 Activity Correlates with the Severity of STEC-HUS.

Biomolecules·2023
Same author

Synergistic Interaction of 5-HT<sub>1B</sub> and 5-HT<sub>2B</sub> Receptors in Cytoplasmic Ca<sup>2+</sup> Regulation in Human Umbilical Vein Endothelial Cells: Possible Involvement in Pathologies.

International journal of molecular sciences·2023

Related Experiment Video

Updated: Jun 9, 2025

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
06:03

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays

Published on: September 20, 2024

1.2K

Immunity and Coagulation in COVID-19.

Piotr P Avdonin1, Maria S Blinova1, Anastasia A Serkova1

  • 1Koltzov Institute of Developmental Biology RAS, ul. Vavilova, 26, 119334 Moscow, Russia.

International Journal of Molecular Sciences
|October 26, 2024
PubMed
Summary
This summary is machine-generated.

Severe COVID-19 can cause life-threatening blood clots due to disruptions in innate immune systems, specifically toll-like receptors (TLRs) and the complement system, leading to immunothrombosis.

Keywords:
COVID-19coagulationcomplementimmunothrombosisinflammationthrombotic microangiopathies

More Related Videos

Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses
09:43

Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses

Published on: March 8, 2024

1.6K
Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients
04:56

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients

Published on: August 4, 2023

693

Related Experiment Videos

Last Updated: Jun 9, 2025

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
06:03

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays

Published on: September 20, 2024

1.2K
Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses
09:43

Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses

Published on: March 8, 2024

1.6K
Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients
04:56

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients

Published on: August 4, 2023

693

Area of Science:

  • Immunology
  • Infectious Diseases
  • Pathophysiology

Background:

  • SARS-CoV-2 caused a global pandemic with significant mortality.
  • While most COVID-19 cases are mild, severe forms can lead to life-threatening complications, including thrombosis.
  • The mechanisms underlying thrombotic complications in severe COVID-19 are not fully understood.

Purpose of the Study:

  • To review the features of immunothrombosis in SARS-CoV-2 infection.
  • To explore the potential underlying mechanisms of immunothrombosis in severe COVID-19.

Main Methods:

  • Review of accumulated data on COVID-19 pathogenesis.
  • Analysis of the roles of innate immune systems in SARS-CoV-2 infection.
  • Examination of the link between immune response, endothelial damage, and hypercoagulation.

Main Results:

  • Severe COVID-19 pathogenesis involves disruptions in innate immune systems, particularly pattern recognition receptors (like toll-like receptors) and the complement system.
  • Dysfunctional innate immunity can trigger an excessive inflammatory response, leading to vascular endothelial damage and a hypercoagulable state.
  • This cascade results in thrombosis and organ damage, a phenomenon termed 'immunothrombosis'.

Conclusions:

  • Disruptions in the innate immune system are key to the development of severe COVID-19 and its thrombotic complications.
  • Understanding immunothrombosis mechanisms is crucial for managing severe SARS-CoV-2 infections.
  • Targeting innate immune pathways may offer therapeutic strategies against COVID-19-associated thrombosis.